Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/1997
10/15/1997EP0800580A1 Method and reagent for prevention, inhibition of progression and regression of vascular diseases
10/15/1997EP0800579A2 Combination gene delivery vehicles
10/15/1997EP0800578A2 Recombinant monoclonal anti-idiotype antibody 3h1 sequences relating to human carcinoembryonic antigen
10/15/1997EP0800575A1 Method for gene transfer into cells activated out of a quiescent state
10/15/1997EP0800403A2 Non-traumatic administration of gene delivery vehicles
10/15/1997EP0800399A1 Combined therapeutical treatment of hyperproliferative diseases
10/15/1997EP0642583B1 Methods and compositions for increasing the sensitivity of a cell to a dna damaging agent
10/15/1997CN1162338A Viable contaminant particle free adenoviruses, their preparation and use
10/15/1997CN1162336A Identification of human cytomegalovirus gene region involved in down-regulation of MHC class I heavy chain expression
10/15/1997CN1162335A Modified human C3 proteins
10/15/1997CN1162266A Novel brain endothelial cell protein and methods for its use
10/14/1997US5677439 Prevention gene expression
10/14/1997US5677428 Mono- or polyclonal antibody raised against human double-stranded rna adenosine deaminase
10/14/1997US5677277 Brain disorders
10/14/1997US5677178 Cytopathic viruses for therapy and prophylaxis of neoplasia
10/14/1997US5677177 FLP-mediated gene modification in mammalian cells, and compositions and cells useful therefor
10/14/1997US5677143 Isolated nucleic acid encoding amino acid sequence of cellular protein
10/14/1997US5676978 Methods of inhibiting undesirable cell growth using a combination of a cyclocreatine compound and a hyperplastic inhibitory agent
10/14/1997US5676954 Administering by injection a nucleic acid-cationic liposome complex capable of functionally expressing the gene to the mammal at a site whereby target organ is the first organ having a capillary bed proximal to site of administeration
10/14/1997US5676946 Phospholipase C homolog
10/14/1997US5676943 Nerve growth factor
10/14/1997US5676646 For implanting molecules into living blood cells
10/13/1997CA2174040A1 Gene therapy for myocardial ischemia
10/09/1997WO1997037225A1 A PROTEIN PREPARATION THAT MEDIATES Ca2+-DEPENDENT TRANSBILAYER MOVEMENT OF PLASMA MEMBRANE PHOSPHOLIPID AND INHIBITORS THEREOF
10/09/1997WO1997037030A1 Method of screening dna-binding protein, plasmid to be used therefor, and dna-binding protein
10/09/1997WO1997037026A1 Novel compounds
10/09/1997WO1997037021A1 Human cystatin f
10/09/1997WO1997037020A1 Apo-2li and apo-3 apoptosis polypeptides
10/09/1997WO1997037016A1 Modulators of tnf receptor associated factor (traf), their preparation and use
10/09/1997WO1997037015A1 Protein with differentiation-inducing activity for friend's erythroleukemia cell lines
10/09/1997WO1997037014A1 Genetic suppression and replacement
10/09/1997WO1997037013A1 Asymmetric hammerhead ribozymes
10/09/1997WO1997036926A1 Growth differentiation factor-14
10/09/1997WO1997036915A1 Human cystatin f
10/09/1997WO1997036578A1 Spray-dried microparticles as therapeutic vehicles for use in gene therapy
10/09/1997WO1997036535A2 Biomarkers for detection, diagnosis and prognosis of prostate cancer
10/09/1997WO1997036481A1 Design of novel highly efficient hiv based packaging systems for gene therapy
10/09/1997WO1997032018A3 Hepatitis c virus ribozymes
10/09/1997WO1997031115A3 Synthetic hiv genes
10/09/1997DE19613691A1 Arzneimittel für die Behandlung von Tumorerkrankungen Drugs for the treatment of tumor diseases
10/09/1997CA2250857A1 Asymmetric hammerhead ribozymes
10/09/1997CA2250478A1 Spray-dried microparticles as therapeutic vehicles for use in gene therapy
10/09/1997CA2250467A1 Biomarkers for detection, diagnosis and prognosis of prostate cancer
10/09/1997CA2250110A1 Growth differentiation factor-14
10/09/1997CA2249349A1 Design of novel highly efficient hiv based packaging systems for gene therapy
10/09/1997CA2249206A1 Apo-2li and apo-3 apoptosis polypeptides
10/09/1997CA2222596A1 Protein with differentiation-inducing activity for friend's erythroleukemia cell lines
10/08/1997EP0799893A1 Defective viral particles obtained in vivo or ex vivo as vaccine
10/08/1997EP0799892A2 Calpain, its production and use
10/08/1997EP0799873A1 Composition for a non-wettable coating, process for treating glazing pane with this composition and the products obtained
10/08/1997EP0799316A1 Recombinant proteinase from clostridium hystolyticum and the use thereof for isolating cells and cell groups
10/08/1997EP0799315A2 Telomerase protein component
10/08/1997EP0799311A1 Human chemokine beta-9
10/08/1997EP0799309A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs
10/08/1997EP0799308A1 Tissue specific hypoxia regulated therapeutic constructs
10/08/1997EP0799243A1 p53 PROTEINS WITH ALTERED TETRAMERIZATION DOMAINS
10/08/1997EP0799059A1 Cationic amphiphiles and plasmids for intracellular delivery of therapeutic molecules
10/08/1997EP0799058A1 Improvements in or relating to endometrial function
10/08/1997EP0777679A4 Delivery of nucleic acids
10/08/1997EP0544757B1 Novel polyamine conjugated oligonucleotides
10/08/1997CN1161715A DNA encoding ovine adenovirus (OAV 287) and its use as a viral vector
10/08/1997CN1161375A Colon bacillus cytosine ammonialyase gene and a new substance containing same
10/07/1997US5675060 Expression of transgene results in mouse having chronic inflammation and deformation of synovial joints; for determining antiarthritic potentials of compositions
10/07/1997US5674995 Oligonucleotides specific for cytokine signal transducer gp130 mRNA
10/07/1997US5674898 Methods and therapeutic compositions for treating cystic fibrosis
10/07/1997US5674734 Cell death protein
10/07/1997US5674722 Genetic modification of endothelial cells
10/07/1997US5674703 Episomal vector systems and related methods
10/07/1997US5674681 Detecting association of a nonclassical major histocompatibility complex with a beta2 microglobin
10/07/1997US5674486 Stimulating immune response against tumor antigen by immunizing with genetic engineered cells
10/07/1997US5674192 Method of gene therapy
10/05/1997CA2201806A1 Novel proteins, their production and use
10/02/1997WO1997035997A2 Recombinant pox virus encoding myelin protein for therapy
10/02/1997WO1997035996A1 Packaging cell line based on human 293 cells
10/02/1997WO1997035995A1 Antitumour cellular compositions expressing at least three transgenes
10/02/1997WO1997035994A2 Cytochrome p450 transducing retroviral vectors
10/02/1997WO1997035993A2 Psa positive regulating (psar) sequences and uses thereof
10/02/1997WO1997035992A1 Tetracycline inducible/repressible systems
10/02/1997WO1997035990A2 Histone deacetylases, and uses related thereto
10/02/1997WO1997035976A2 Epidermal differentiation factor
10/02/1997WO1997035974A1 Sequences ahead of gene sm22, vectors containing same, and therapeutical uses thereof, particularly for treating vascular diseases
10/02/1997WO1997035971A1 A NOVEL MAMMALIAN GENE, bcl-w, BELONGS TO THE bcl-2 FAMILY OF APOPTOSIS-CONTROLLING GENES
10/02/1997WO1997035964A1 Fine magnetic particles containing useful proteins bound thereto, process for producing the same, and use thereof
10/02/1997WO1997035870A1 Growth factor htter36
10/02/1997WO1997035619A1 Opsonin-enhanced cells, and methods of modulating an immune response to an antigen
10/02/1997WO1997035595A1 Egg anti-inflammatory composition, method of isolation and use
10/02/1997WO1997035478A1 Selective target cell activation by expression of a g protein-coupled receptor activated superiorly by synthetic ligand
10/02/1997WO1997035477A1 Use of mutant alkyltransferases for gene therapy to protect from toxicity of therapeutic alkylating agents
10/02/1997WO1997029201A3 Retroviral vector for the gene transfer of an il6 antagonist in human haematopoietic stem cells
10/02/1997WO1997029113A3 Process for preparing purified nucleic acid and the use thereof
10/02/1997WO1997026910A3 Tumour vaccine for immunotherapy of malignant tumours
10/02/1997WO1997026331A3 Use of neuronal apoptosis inhibitor protein (naip)
10/02/1997WO1997023611A3 Nucleic acid sequences of genes of the high mobility group proteins and uses thereof
10/02/1997WO1997019675A3 Complex cationic lipids
10/02/1997WO1997019181A3 Virus vector for the transfer of stable episomes
10/02/1997WO1997014797A3 Cystatin m, a novel cysteine proteinase inhibitor
10/02/1997WO1997011176A3 Cyclin/cdk associated proteins, and uses related thereto
10/02/1997DE19612463A1 Neues Protein mit differenzierungsinduzierender Aktivität für erythropoetische Zellen Novel protein differenzierungsinduzierender activity for erythropoietic cells
10/02/1997CA2250332A1 Antitumour cellular compositions expressing at least three transgenes
10/02/1997CA2250207A1 A novel mammalian gene, bcl-w, belongs to the bcl-2 family of apoptosis-controlling genes
1 ... 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 ... 870